No Data
Company Research Report: Solvvy Inc. (7320)
Solvvy--- "Neuro Switch for Wellness" has started selling.
On the 1st, Solvvy <7320> announced that its subsidiary Broadcasting Seek has started selling a brain training Commodity ETF called "Neuro Switch for Wellness," aimed at preventing dementia, alleviating physical pain, and reducing stress. The product consists of a brain wave measurement device and a neurofeedback practice guidebook, and includes a one-year product warranty from the date of purchase. Moreover, there are effects demonstrated in medical papers regarding the improvement of short-term memory and the relief of chronic pain.
Solvvy—official establishment of the cutting-edge technology research institute "Solvvy LAB."
On the 11th, Solvvy <7320> officially announced the establishment of its advanced technology research institution, "Solvvy LAB." The company has previously collaborated with the Hospital Pain Center of the University of Tokyo and the Hospital affiliated with Chiba University, focusing on research related to brain waves (neurofeedback) through its subsidiary, MediaSeek, and has utilized the results in product development. Additionally, in February 2025, a guarantee service utilizing AI diagnostic technology for onboard Batteries of EVs will be launched.
Solvvy: Extraordinary Report
Solvvy---partnered with Denchi to start a demonstration experiment on 'EV range guarantee.'
On the 26th, Solvvy <7320> announced that it will begin a proof-of-concept for a guarantee service "denchi.ai range guarantee" utilizing AI diagnostic technology for onboard Batteries of EVs (including hybrid vehicles) in partnership with Denchi (headquartered in Honjo City, Saitama Prefecture). In recent years, with the spread of EVs, the importance of Circular Economy initiatives such as the reuse and recycling of onboard Batteries has been increasing, with the domestic market size expected to reach 80 trillion yen by 2030.
Express News | [Change Report] Mr. Yoshitaka Adachi reported a decrease in Shareholding of Solvvy (7320.JP) to 13.5%.